Insulin glargine 300 U/ml versus insulin degludec 100 U/ml improves nocturnal glycaemic control and variability in type 1 diabetes under routine clinical practice: A glucodensities‐based post hoc analysis of the OneCare study

Saved in:
Bibliographic Details
Published inDiabetes, obesity & metabolism Vol. 26; no. 5; pp. 1993 - 1997
Main Authors Gomez‐Peralta, Fernando, Chico Ballesteros, Ana, Marco Martínez, Amparo, Pérez Corral, Begoña, Conget Donlo, Ignacio, Fuentealba Melo, Paulina, Zaragozá Arnáez, Fernando, Matabuena Rodríguez, Marcos
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.05.2024
Subjects
basal insulins
Blood Glucose
continuous glucose monitoring
diabetes mellitus
Diabetes Mellitus, Type 1 - drug therapy
glucodensity
Glycemic Control
Humans
Hypoglycemic Agents - therapeutic use
Insulin Glargine - adverse effects
Insulin, Long-Acting - adverse effects
diabetes mellitus
continuous glucose monitoring
basal insulins
glucodensity
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:1462-8902
1463-1326
DOI:10.1111/dom.15496